Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients

NCT05487248 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT05487248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05487248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients
Lead sponsor
Jules Bordet Institute
Phase
Not applicable
Overall status
Completed
Start date
October 12, 2023
Completion date
August 24, 2026
Enrollment
103 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

candidate for third-line or subsequent lines of therapy, metastatic colorectal cancer, unresectable locally advanced colorectal cancer